These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26706999)

  • 1. Opening a Pandora's (F)-box in cancer.
    Azmi AS
    Semin Cancer Biol; 2016 Feb; 36():1-2. PubMed ID: 26706999
    [No Abstract]   [Full Text] [Related]  

  • 2. Small molecule therapeutics targeting F-box proteins in cancer.
    Liu Y; Mallampalli RK
    Semin Cancer Biol; 2016 Feb; 36():105-19. PubMed ID: 26427329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulating Fbw7 on the road to cancer.
    Xu W; Taranets L; Popov N
    Semin Cancer Biol; 2016 Feb; 36():62-70. PubMed ID: 26459133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of F-BOX proteins in progression and development of human malignancies.
    Uddin S; Bhat AA; Krishnankutty R; Mir F; Kulinski M; Mohammad RM
    Semin Cancer Biol; 2016 Feb; 36():18-32. PubMed ID: 26410033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F-box protein interactions with the hallmark pathways in cancer.
    Randle SJ; Laman H
    Semin Cancer Biol; 2016 Feb; 36():3-17. PubMed ID: 26416465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial overview: cancer: from target discovery to targeted therapy: the risky business of target validation.
    Cruzalegui F
    Curr Opin Pharmacol; 2014 Aug; 17():iv-vi. PubMed ID: 25220882
    [No Abstract]   [Full Text] [Related]  

  • 7. [Function and mechanism of tumor suppressor gene FBW7 in tumorigenesis].
    Huang HJ; Zheng F; Xu FP; Liu YH; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):214-6. PubMed ID: 23769449
    [No Abstract]   [Full Text] [Related]  

  • 8. F-box proteins: Keeping the epithelial-to-mesenchymal transition (EMT) in check.
    Díaz VM; de Herreros AG
    Semin Cancer Biol; 2016 Feb; 36():71-9. PubMed ID: 26506454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fbw7 and its counteracting forces in stem cells and cancer: Oncoproteins in the balance.
    Cremona CA; Sancho R; Diefenbacher ME; Behrens A
    Semin Cancer Biol; 2016 Feb; 36():52-61. PubMed ID: 26410034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the ubiquitin ligase Fbw7 in cancer progression.
    Cheng Y; Li G
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):75-87. PubMed ID: 22124735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of estrogen-induced F-box protein FBXO45.
    Yoshida K
    Oncol Rep; 2005 Aug; 14(2):531-5. PubMed ID: 16012741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted silencing of Jab1/Csn5 in human cells downregulates SCF activity through reduction of F-box protein levels.
    Cope GA; Deshaies RJ
    BMC Biochem; 2006 Jan; 7():1. PubMed ID: 16401342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function and mechanism of F-box proteins in gastric cancer (Review).
    Gong J; Cao J; Liu G; Huo JR
    Int J Oncol; 2015 Jul; 47(1):43-50. PubMed ID: 25955829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
    Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
    Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemistry. Plant hormone's long-sought receptor found.
    Ferber D
    Science; 2005 May; 308(5726):1240. PubMed ID: 15919964
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term effects of systemic cancer treatment on DNA oxidative damage: the potential for targeted therapies.
    Vera-Ramirez L; Ramirez-Tortosa M; Perez-Lopez P; Granados-Principal S; Battino M; Quiles JL
    Cancer Lett; 2012 Dec; 327(1-2):134-41. PubMed ID: 22274413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of acquired resistance to targeted cancer therapies.
    Lackner MR; Wilson TR; Settleman J
    Future Oncol; 2012 Aug; 8(8):999-1014. PubMed ID: 22894672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curing "incurable" cancer.
    Watson JD
    Cancer Discov; 2011 Nov; 1(6):477-80. PubMed ID: 22586652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancer targeted therapy and resistance signals].
    Yano S
    Seikagaku; 2013 Jun; 85(6):475-83. PubMed ID: 23875476
    [No Abstract]   [Full Text] [Related]  

  • 20. The Role of miR-21 in Cancer.
    Pfeffer SR; Yang CH; Pfeffer LM
    Drug Dev Res; 2015 Sep; 76(6):270-7. PubMed ID: 26082192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.